RecallDepth
Class II Ongoing

Elitek (rasburicase) for injection, 7.5 mg vial, Rx Only Mfd. by Sanofi - Aventis U. S. LLC Bridgewater, NJ, 08807, NDC 0024-5151-75

Company
Sanofi-Aventis U.S. Llc
Recall Initiated
August 10, 2020
Posted
August 26, 2020
Recall Number
D-1507-2020
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
7451 vials
Firm Location
Bridgewater, NJ, United States

Reason for Recall

Failed Stability Specifications: Out of Specification result for enzyme activity levels noted during routine stability testing.

Distribution

Nationwide in the US

Lot / Code Info

Lot #: A9306, Exp 2/28/2022

More recalls by Sanofi-Aventis U.S. Llc

View all recalls by this company →

Other recent Class II Drug recalls